Goldman Sachs commanded 11.8 percent of all healthcare fees,
followed by JP Morgan with 11.2 percent and Morgan Stanley
with 6.9 percent.
Healthcare has seen a record wave of deal-making since the start
of 2014, stretching from large drugmakers buying up smaller
rivals to consolidation among makers of generic medicines to
tie-ups between insurers.
The buoyant healthcare market contrasts with an 8 percent fall
in overall first-half global investment banking fees, which
cover services ranging from M&A advisory work to capital markets
underwriting.
JP Morgan topped the overall global investment banking league
table during the first six months of 2015, with Goldman Sachs in
second place.
(Reporting by Ben Hirschler; Editing by Greg Mahlich)
[© 2015 Thomson Reuters. All rights
reserved.] Copyright 2015 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|